Trusted information on liver disease, transplant surgery, and hepatology — written for patients and families navigating liver health by Dr. Srinivas Bojanapu, Liver Transplant Surgeon, Bangalore.
Fatty Liver
MASLD (formerly NAFLD) now affects 1 in 3 Indians. What most people don't realise is that it can silently progress to cirrhosis — and then to liver cancer — over 10–20 years, often with no symptoms until it's advanced. Dr. Srinivas explains the progression, who's at risk, and what to do now.
Read Article →
Transplant
The choice between deceased donor and living donor transplant depends on your MELD score, urgency, and whether a suitable family donor is available. Here's a comprehensive comparison.
Read Article →
Hepatitis
Modern Direct Acting Antivirals (DAAs) cure hepatitis C in 8–12 weeks with minimal side effects. Yet millions of Indians remain undiagnosed or untreated. Here's what you need to know.
Read Article →
Robotic Surgery
The Whipple's procedure is one of the most complex operations in surgery. The robotic approach offers precision advantages — but is it the right choice for every patient? An honest assessment.
Read Article →
Patient Guide
What to expect after discharge — medications, diet, restrictions, follow-up schedule, warning signs, and when you can return to normal life. A comprehensive guide from the transplant team.
Read Article →
Liver Cancer
Hepatocellular carcinoma (liver cancer) caught at Stage I has a 5-year survival over 70%. Caught at Stage III — under 10%. Regular surveillance ultrasound is the single most impactful thing a cirrhosis patient can do.
Read Article →Send your question or medical reports to Dr. Srinivas's team — we'll triage and respond with guidance or schedule a consultation.
